PDB Reference: calcium-bound human S100A13, 2egd, r2egdsf. S100A13 is a member of the S100 family of EF-hand-containing calcium-binding proteins. S100A13 plays an important role in the secretion of fibroblast growth factor-1 and interleukin 1, two pro-angiogenic factors released by the nonclassical endoplasmic reticulum/Golgi-independent secretory pathway. The X-ray crystal structure of human S100A13 at pH 7.5 was determined at 1.8 Å resolution. The structure was solved by molecular replacement and was refined to a final R factor of 19.0%. The structure revealed that human S100A13 exists as a homodimer with two calcium ions bound to each protomer. The protomer is composed of four -helices ( 1 -4 ), which form a pair of EF-hand motifs. Dimerization occurs by hydrophobic interactions between helices 1 and 4 and by intermolecular hydrogen bonds between residues from helix 1 and the residues between 2 and 3 of both chains. Despite the high similarity of the backbone conformation in each protomer, the crystal structures of human S100A13 at pH 7.5 (this study) and at pH 6.0 [Li et al. (2007) , Biochem. Biophys. Res. Commun. 356, 616-621] exhibit recognizable differences in the relative orientation ($2.5 ) of the protomers within the dimer and also remarkable differences in the side-chain conformations of several amino-acid residues.
1. Introduction S100-family proteins are small acidic calcium-binding proteins containing two EF-hand motifs: a canonical EF-hand at the C-terminus and an S100-specific EF-hand at the N-terminus. They are expressed in a cell-and tissue-specific manner and have been implicated in intracellular and extracellular regulatory activities (Donato, 1999) . Most S100 members exist as homodimers or heterodimers. S100A13 is one of the most recently identified members of the S100 family. Human S100A13 consists of 98 amino-acid residues and has a molecular weight of 11 kDa. Unlike most members of this family, S100A13 is ubiquitously expressed in various tissues (Wicki et al., 1996) and does not expose hydrophobic patches upon Ca 2+ binding, which is thought to be essential for the interaction of the other S100 proteins with their target proteins (Ridinger et al., 2000) . S100A13 participates in the stress-induced release of the proangiogenic polypeptides fibroblast growth factor-1 (FGF-1) and interleukin 1 (IL-1), which are secreted by the nonclassical endoplasmic reticulum/Golgi-independent pathway (Carreira et al., 1998; Mandinova et al., 2003; Prudovsky et al., 2003) . The crystal structures of FGF-1 and IL-1 demonstrated remarkable structural similarity, despite the absence of sequence similarity (Thomas et al., 1985; Zhang et al., 1991) . Both Ca 2+ and Cu 2+ ions are needed for the interaction of S100A13 with these proteins (Landriscina et al., 2001) . The binding of Ca 2+ to S100A13, which is triggered by Ca 2+ influx through N-type Ca 2+ channels (Matsunaga & Ueda, 2006) , is likely to form the Cu 2+ -binding sites on S100A13 (Arnesano et al., 2005) . The solution structures of human S100A13 at pH 5.6 in the presence and absence of Ca 2+ (PDB codes 1yut and 1yur, respectively) have been reported (Arnesano et al., 2005) . In addition, the 2.0 Å crystal structure of human S100A13 at pH 6.0 in the presence of Ca 2+ has very recently been reported (Li et al., 2007) . Here, we report the 1.8 Å crystal structure of the Ca 2+ -bound form of homodimeric human S100A13 at the physiological pH 7.5 and compare it with the solution structures at pH 5.6 and the crystal structure at pH 6.0.
Materials and methods

Expression and purification
Human S100A13 cDNA (GenBank accession No. AK097132) cloned from a first-strand cDNA library from human spleen (Origene Technologies) was amplified by polymerase chain reaction (PCR) and subcloned into the NdeI/BamHI site of pET-16b vector (Novagen). Escherichia coli BL21(DE3) cells harbouring the expression vector pET-16b-human S100A13 were grown at 310 K. The expression of S100A13 with an N-terminal 10ÂHis tag was induced at an OD 600 of 0.6 with 1 mM isopropyl -d-1-thiogalactopyranoside (IPTG) and the culture was continued at 310 K for 4 h. The cells were harvested by centrifugation at 3000g for 10 min at 277 K, disrupted by sonication and centrifuged at 26 000g for 20 min at 277 K. The supernatant was applied onto a His-Bind affinity chromatography column precharged with Ni 2+ (Novagen). The 10ÂHis-tagged human S100A13 eluted from the resin was digested with factor Xa protease (Novagen, 10 U enzyme per milligram of protein substrate) at room temperature for 4 h, which resulted in human S100A13 with one additional histidine residue at the N-terminus. The cleaved protein was subjected to an Econo-Pac High Q (Bio-Rad) anion-exchange column equilibrated with 25 mM Tris-HCl pH 8.1 and eluted with a linear gradient of 0-0.1 M NaCl. Fractions containing the purified S100A13 were concentrated to 7.4 mg ml À1 .
Crystallization and data collection
Crystallization experiments were performed using the hangingdrop vapour-diffusion method. Calcium chloride was added to the protein solution to a final concentration of 2 mM prior to crystallization in order to obtain the calcium-bound form of S100A13. Crystals were obtained in two weeks by mixing 0.5 ml protein solution protein structure communications Three-dimensional structures of human S100A13. (a) Ribbon diagrams showing the crystal structures of a Ca 2+ -bound S100A13 homodimer at pH 7.5 (CAL7.5; PDB code 2egd) and at pH 6.0 (CAL6.0; PDB code 2h2k) and the solution structures of Ca 2+ -bound and Ca 2+ -free S100A13 at pH 5.6 (CAL5.6 and APO5.6; PDB codes 1yut and 1yur, respectively). The helices in chain A are labelled 1 , 2 , 3 , 4 and the helices in chain B are labelled 1 0 , 2 0 , 3 0 , 4 0 . Ca 2+ ions are shown as orange spheres. (b) Comparison between the CAL7.5 and CAL6.0 backbone structures. When the B chains of CAL7.5 (blue) and CAL6.0 (yellow) are superposed, the A chains (pink and green lines for CAL7.5 and CAL6.0, respectively) are placed in slightly different orientations.
(7.4 mg ml À1 in 25 mM Tris-HCl pH 8.1, 0.1 M NaCl and 2 mM CaCl 2 ) and 0.5 ml of a reservoir solution consisting of 22%(w/v) PEG 3350, 0.1 M HEPES-NaOH pH 7.5, 0.2 M NaCl and 1.5%(w/v) 1,2,3heptanetriol. The drop was equilibrated against 500 ml reservoir solution at 293 K.
X-ray diffraction data were collected on beamline BL41XU at SPring-8 (Harima, Japan). The wavelength was set to 1.000 Å and the distance between the crystal and the detector was set to 200 mm. The diffraction data were indexed, integrated and scaled using HKL-2000 (Otwinowski & Minor, 1997) . The best crystal diffracted X-rays beyond 1.8 Å resolution and the diffraction data set was scaled to 1.80 Å resolution. The crystal belonged to space group P2 1 2 1 2 1 , with unit-cell parameters a = 39.8, b = 59.3, c = 77.6 Å . The crystal contains two S100A13 molecules in the asymmetric unit (V M = 2.0 Å 3 Da À1 , solvent content = 38%).
Structure determination and refinement
The structure of S100A13 was solved using the CCP4 program suite (Collaborative Computational Project, Number 4, 1994) . Molecular replacement with MOLREP (Vagin & Teplyakov, 1997) produced a good solution when the protein atomic coordinates of S100A8 in the S100A8-S100A9 heterodimer (PDB code 1xk4; I. P. Korndoerfer, F. Brueckner & A. Skerra, unpublished results) were used as the search model. Initial model building was performed with ARP/wARP (Perrakis et al., 1999) . Iterative model fitting and restrained refinement were performed with Coot (Emsley & Cowtan, 2004) and REFMAC5 (Murshudov et al., 1997) . The two S100A13 molecules in the asymmetric unit (chains A and B) formed a homodimer. TLS (Winn et al., 2001) and restrained refinement in REFMAC5 was used as the final refinement, in which the chains A and B were divided into 14 and 15 TLS groups, respectively. The refined structure was validated with PROCHECK (Laskowski et al., 1993) . The refined 1.80 Å structure has an R factor of 19.0% and a free R of 22.7%. The data-collection and refinement statistics are shown in Table 1 . Molecular graphics were generated with PyMOL (DeLano, 2002). Dimer-interface interactions were analyzed with PISA (Krissinel & Henrick, 2005) . Interhelical angles were calculated with MOLMOL (Koradi et al., 1996) . Superpositions of threedimensional protein structures were made with CCP4. The atomic coordinates and experimental structure factors of human S100A13 at pH 7.5 have been deposited in the PDB under code 2egd, where chains A and B correspond to chains A and B of PDB entry 2h2k, the crystal structure of human S100A13 at pH 6.0 with the same space group P2 1 2 1 2 1 and similar unit-cell parameters a = 40.2, b = 60.7, c = 78.5 Å (Li et al., 2007) .
Results and discussion
The crystallization and preliminary X-ray analysis of S100A13 have previously been reported (Imai et al., 2006) . The 1.8 Å crystal structure of human S100A13 at pH 7.5 (referred to in this paper as CAL7.5; PDB code 2egd) was solved by molecular replacement (Fig. 1a ). S100A13 exists as a homodimer (chains A and B) with two Ca 2+ ions bound to each protomer. Each protomer is composed of four -helices ( 1 -4 ), which form a pair of EF-hand motifs. The N-terminal EF-hand (EF1) is composed of helix 1 (Glu8-Ala24), a Ca 2+ -binding loop (Arg25-Ser34) and helix 2 (Val35-Gln45). The C-terminal EF-hand (EF2) is composed of helix 3 (Leu56-Leu63), a second Ca 2+ -binding loop (Asp64-Tyr72) and helix 4 (Phe73-Tyr90). These EF-hands are joined by a hinge region (Leu46-Ser55).
To date, three structures of human S100A13 have been reported: solution structures at pH 5.6 of the Ca 2+ -bound form (CAL5.6; PDB code 1yut) and of the apo form (APO5.6; PDB code 1yur) (Arnesano et al., 2005) Fig. 1a ). The atomic (C ) r.m.s. differences between our crystal structure (CAL7.5) and these structures at different pH values are shown in Table 2 . Comparison with the solution structures shows that CAL7.5 is moderately similar to CAL5.6, while it shows less similarity to APO5.6 because of the conformational changes that occur upon Ca 2+ binding (Fig. 2a ). The two crystal structures CAL7.5 and CAL6.0 were both obtained from P2 1 2 1 2 1 crystals grown by the hanging-drop vapour-diffusion method and had similar unit-cell parameters. The CAL7.5 crystal (P2 1 2 1 2 1 ; a = 39.8, b = 59.3, c = 77.6 Å ) was obtained from nontagged human S100A13 at pH 7.5 and 293 K with 22%(w/v) PEG 3350 as the precipitant in the presence of 2 mM Ca 2+ , whereas the CAL6.0 crystal (P2 1 2 1 2 1 ; a = 40.2, b = 60.7, c = 78.5 Å ) was obtained from human S100A13 with an N-terminal 6ÂHis tag at pH 6.0 and 277 K with 25%(v/v) PEG MME 550 as the precipitant in the presence of 10 mM Ca 2+ . Chains A and B of CAL7.5 correspond to chains A and B of CAL6.0, respectively. CAL7.5 and CAL6.0 are quite similar, with atomic (C ) r.m.s. differences of 0.25 and 0.26 Å for chains A and B, respectively, and of 0.31 Å overall (Table 2) . However, there are recognizable differences between CAL7.5 and CAL6.0 ($2.5 ) in the relative orientations of the protomers within the dimer; when the B chains of CAL7.5 and CAL6.0 are superposed, the helices in their A chains are differently oriented by 2.2 ( 2 ), 2.7 ( 3 ) and 2.6 ( 4 ) (Fig. 1b) . Consistently, relatively large r.m.s. differences are seen in helices 2 , 3 and 4 as well as in the Ca 2+ -binding loops (Figs. 1b and  2) . In addition, side-chain conformational differences are observed for Arg25, Leu41, Ser62, Asn66, Lys72, Asn74, Lys85 and Arg88 in the A chains of CAL7.5 and CAL6.0 and for Arg25, Gln26, Glu40, Thr43, Pro47, His48 and Glu82 in the B chains of CAL7.5 and CAL6.0 (Fig. 3) . With the exception of that of Leu41, all of these side chains are exposed to solvent, indicating that the exposed side chains underwent conformational adjustments when incorporated into the P2 1 2 1 2 1 crystals at different pH values. On the other hand, the side chain of Leu41 is buried in the molecule and is involved in the hydrophobic cluster. The side-chain conformations of the Leu41 residues in chains A and B of CAL7.5 and in chain B of CAL6.0 are almost the same ( 2 = 149.2 AE 3.9 ), whereas that in chain A of CAL6.0 differs ( 2 = 87.1 ). Since the side chains of the four Leu41 residues fit well to the respective 2F o À F c electron densities with no recognizable F o À F c densities (Fig. 3) , the side chain of Leu41 of S100A13 can adopt two conformations at pH 6.0. Since most human cells maintain the cytosolic pH at about 7.2 (Alberts et al., 2002) , our crystal structure at pH 7.5 (CAL7.5) should reflect the physiologically active form of S100A13.
In the S100-specific EF-hand (EF1) the main-chain carbonyl O atoms of Ala24, Glu27, Arg29 and Ser32, the side-chain O atoms of Glu37 and a water O atom coordinate to a Ca 2+ ion (Fig. 4a) , while in the canonical EF-hand (EF2) the main-chain carbonyl O atom of Glu70, the side-chain O atoms of Asp64, Asn66, Asp68 and Glu75, and a water O atom coordinate to a Ca 2+ ion (Fig. 4b) . A water molecule of EF1 might interact with the side chain of Glu70 in EF2, forming a possible site of cooperativity of the two EF-hands, as observed by Li et al. (2007) . The presence of Arg29 in the Z position in EF1 of S100A13 is unusual among the Ca 2+ -binding loops of EFhand proteins (Marsden et al., 1990) . S100A13 differs in Ca 2+ -binding affinity from other S100 proteins. In general, the four Ca 2+ -binding sites of homodimeric S100 proteins, e.g. S100A2, S100A3, S100A4, S100A5, S100A6 and S100A11, display almost equal affinities for Ca 2+ ions and a positive cooperativity (Heizmann & Cox, 1998) . In contrast, those in S100A13 display two different sets of affinities for Ca 2+ ions (Ridinger et al., 2000) , which indicates that the unusual Arg in the Z position of EF1 in S100A13 probably diminishes the Ca 2+binding affinity.
The dimer interface of S100A13 has an accessible surface area of 1380 Å 2 , covering approximately 24% of the total accessible surface area of each protomer. The interface residues are located in helices 1 and 4 and in the hinge region between 2 and 3 . The dimer interface is mainly built up by hydrophobic interactions between 1 and 1 0 , 4 protein structure communications Atomic (C ) r.m.s. difference of each residue between CAL7.5 and CAL6.0. The r.m.s. differences between the A chains are shown as thin lines and those between the B chains are shown as thin dashed lines when the corresponding chains are superposed. The r.m.s. differences between the A chains are shown as thick lines and those between the B chains are shown as thick dashed lines when the other chains are superposed. Residues that participate in interchain hydrogen bonds and hydrophobic interactions are indicated by spheres and white triangles, respectively. Ca 2+ -binding residues are indicated by black triangles. Secondary-structure elements are shown below the graph. and 4 0 , 1 and 4 0 , and 4 and 1 0 (Figs. 5a, 5b and 5c ). The intermolecular hydrogen bonds are mainly located between 1 and the hinge region of the other protomer, as shown in Fig. 5(d) . The pattern of intermolecular interactions is similar to those found in the S100A6 homodimer (PDB code 1k9k; Otterbein et al., 2002) and the S100A8/-S100A9 heterodimer (PDB code 1xk4). The dimer-interface residues located in helix 1 and the hinge region between 2 and 3 are well conserved among these S100-family proteins. Amino-acid residues with different side-chain conformations in CAL7.5 and CAL6.0. The amino-acid residues and their electron densities were coloured pink, blue, green and yellow for CAL7.5 chain A, CAL7.5 chain B, CAL6.0 chain A and CAL6.0 chain B, respectively. S100A13 can form a multiprotein complex with FGF-1 and p40 synaptotagmin (Carreira et al., 1998; Landriscina et al., 2001) . This ternary complex formation is essential for the stress-induced release of FGF-1, which is inhibited by the anti-inflammatory drug amlexanox (Carreira et al., 1998) , a specific binder of S100A13 (Shishibori et al., 1999) . FGF-1 is a pro-angiogenic factor that induces endothelial cell proliferation and differentiation and plays an important role in chronic inflammatory diseases (Lai & Adams, 2005) such as rheumatoid arthritis (Malemud, 2007) . A VAST structural-homology search (http://www.ncbi.nlm.nih.gov/structure/VAST/vastsearch.html) revealed the structural similarity of the S100A13 homodimer (CAL7.5) to the S100A8-S100A9 heterodimer (PDB code 1xk4) and the S100A1 homodimer (PDB code 1zfs; Wright et al., 2005) , with r.m.s. differences of 1.2 and 2.5 Å , respectively. Interestingly, these structurally similar proteins are functionally related to inflammatory conditions. The S100A1 homodimer binds amlexanox (Okada et al., 2002) as does S100A13, while the S100A8-S100A9 heterodimer, which is implicated in Ca 2+ -dependent functions during inflammation (Odink et al., 1987) , is expressed in human peripheral blood mononuclear cells under inflammatory conditions and in rheumatoid arthritis (Brun et al., 1992) .
The basic C-terminal part of S100A13 has a flexible character as in S100A9 (Itou et al., 2002) as shown by the unobserved electron densities for the C-terminal eight and three residues (91-98 and 96-98) in chains A and B of CAL7.5, respectively. The C-terminus of chain B is less flexible owing to the crystal packing. Since the C-terminal region is implicated in intermolecular interaction with FGF-1 and amlexanox, the flexible character of this region would be important for the ternary complex formation for FGF-1 secretion (Landriscina et al., 2001) .
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